Louis Koné

Structure and negotiate out-licensing agreements, R&D collaborations and service agreements with biotech companies, pharmaceutical groups and VC funds. Build and analyze financial deal models (upfronts, development and sales milestones, royalties) to support license negotiation strategy and transaction decision-making. Lead interactions with venture capital funds and pharmaceutical BD teams as primary counterparts for partnership discussions.

Business Developer - INSERM TRANSFERT - Paris, France

(2025-05)

• Structure and negotiate out-licensing agreements, R&D collaborations and service agreements with biotech companies, pharmaceutical groups and VC funds.
• Build and analyze financial deal models (upfronts, development and sales milestones, royalties) to support license negotiation strategy and transaction decision-making.
• Lead interactions with venture capital funds and pharmaceutical BD teams as primary counterparts for partnership discussions.

Venture Capital Analyst Intern - SOFINNOVA PARTNERS (>€4B AUM) - Paris, France – London, UK

(2024-09 - 2025-04)

• Contributed to healthcare investment processes through scientific, clinical and commercial due diligence.
• Screened and analyzed companies across multiple therapeutic areas and modalities; conducted introductory calls with management teams.
• Performed targeted research into specific scientific fields, applying a scientifically driven approach to uncover new investment opportunities.
• Prepared LP-facing analyses and presentation materials in support of fundraising and fund closing activities, in coordination with the Investor Relations team.
• Gathered intelligence on Pharma, Biotech and MedTech sectors to monitor market developments relevant to the portfolio

Analyst Intern - AGILE CAPITAL MARKETS (Healthcare Investment Bank) - Paris, France

(2024-04 - 2024-09)

• Worked on Series A and later-stage fundraising mandates for biotechnology, medtech and healthcare services companies.
• Prepared investor pitch decks with CEOs, focusing on equity story and strategic positioning.
• Performed valuation analyses using public and private comparables and precedent transactions in the context of M&A mandates.
• Supported licensing transactions, including term analysis and identification of potential pharmaceutical partners.

CEO Right-hand Intern - SCIENTA LAB (immuno-inflammation AI start-up) - Paris, France

(2023-05 - 2023-07)

• Performed market and competitive analyses on clinical-stage immunology assets.
• Supported seed fundraising activities, including investor targeting and preparation of investor materials.

MSc - Pharmaceutical and Biotechnology Management - ESCP Business School (2023 - 2024) Paris, France – London, UK

Doctor of pharmacy - PharmD - University of Bordeaux (2017 - 2024) Paris, France